Overview
Beth Shafer holds a PhD in Biology from UC San Diego [11] and earned both an MPhil and MA in Cellular and Molecular Biophysics from Columbia University Vagelos College of Physicians and Surgeons [12][13]. Shafer currently serves as Venture Partner & Strategic Advisor at Mubadala Capital [1][4] and Chief Business Officer at Windward Bio [3]. Shafer's prior roles include Chief Business Officer at Scholar Rock and Voyager Therapeutics [5], Vice President & Head of Takeda Business Development [6], Head of Ophthalmology and Disease Area X Business Development & Licensing at Novartis Institutes for BioMedical Research [9], and Director of Global Business Development at Roche Partnering [10]. Shafer has also served on the boards of Aquinnah Pharmaceuticals and Arcellx, Inc. [7][8]. Shafer's background encompasses corporate and business development leadership across neurosciences, gastroenterology, ophthalmology, gene and cellular therapies, and diagnostics [2].
Profile introduction
Global executive with a proven track record of establishing and leading global corporate and business development groups in Neurosciences, Gastroenterology, Ophthalmology, Disruptive technologies, Gene and Cellular therapies, Metabolic drugs, Diagnostics, Externalizations and more. Extensive experience in building industry leading portfolios by enabling strategic growth through seminal transactions, negotiating fit for purpose win-win structured agreements, building world class partnering teams; and have proven effective in building new therapeutic area pillars for several Pharma companies. L…
Career history
- Chief Business OfficerMay 2026 to presentWindward Bio
- Venture Partner & Strategic AdvisorOct 2023 to presentMubadala Capital
- Chief Business Officer (SRRK; VYGR)Aug 2023 to May 2025Scholar Rock; Voyager Therapeutics
- Vice President & Head, Takeda Business Development (GI2, NS, DDS, Exts)Dec 2018 to Jul 2023Takeda
- Member of the BoardJan 2019 to Jun 2023Aquinnah Pharmaceuticals
- Member of the BoardJul 2021 to Mar 2022Arcellx, Inc.
- Head, Ophthalmology and Disease Area X (DAx), NIBR Business Development & LicensingJan 2017 to Dec 2018Novartis Institutes for BioMedical Research (NIBR)
- Director, Global Business Development, Roche Partnering2011 to 2017Roche
Education
PhD, BiologyUC San Diego
- MPhil, Cellular and Molecular BiophysicsColumbia University Vagelos College of Physicians and Surgeons
- MA, Cellular and Molecular BiophysicsColumbia University Vagelos College of Physicians and Surgeons
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.